PHOENIX Pharmahandel GmbH & Co KG entered into an agreement to acquire Certain European Businesses of McKesson Europe AG for approximately $1.5 billion on July 5, 2021. Purchase price is subject to certain adjustments under the agreement. This transaction also includes McKesson?s German-based AG headquarters in Stuttgart, Recucare GmbH, its German wound-care business, its shared services center in Lithuania, and its 45% ownership stake in Brocacef, the company?s joint venture in the Netherlands. McKesson will also retain its minority equity stake in the company?s Germany joint venture with Walgreens Boots Alliance. The transaction is subject to customary closing conditions, including receipt of required regulatory approvals. The transaction is expected to close in 2022. On August 4, 2021, transaction is expected to close in fiscal 2023. As per update on May 5, 2022, McKesson Corporation anticipate to close the transaction in fiscal 2023. Rainer Loges, Martin Schockenhoff, Julius Scheifele, Jan Philipp Mohr, Markus Braun, Friedrich Baumgärtel, Johannes Culmann, Stephanie Lumpp, Matthias Karl, Philipp Pichler, Patrick Grüner, Lukas Aberle, Alexandra Bruch, Daniela Drixler, Juliane Langguth, Doris-Maria Schuster, Frauke Sturm, Matthias Böglmüller, Daniela Mayr, Jacob von Andreae, Marco König, Aylin Hoffs, Matthias Hahn, Rafael Müller, Matthias Werner, Manuel Klar, Theresa Uhlenhut, Michael Feilke, Sebastian Girschick, Johann Wagner, Hendrik Marchal, Thomas Kulzer and Jana Pinto Escaleira of Gleiss Lutz acted as legal advisor to PHOENIX Pharmahandel GmbH. Deutsche Bank Securities Inc. acted as financial advisor to Phoenix Group in the transaction. Stephen M. Kotran of Sullivan & Cromwell LLP represents Goldman Sachs & Co., LLC as financial adviser to McKesson Corporation. João Mattamouros Resende of Cuatrecasas, Gonçalves Pereira & Associados R.L. acted as legal advisor to Phoenix Group.

PHOENIX Pharmahandel GmbH & Co KG completed the acquisition of Certain European Businesses of McKesson Europe AG on October 31, 2022. For the time being, PHOENIX Pharmahandel GmbH & Co KG will continue to operate the brands established locally by McKesson Europe in the pharmaceutical wholesale and pharmacy retail business.